Alzheimers and Dementia Translational Research and Clinical Interventions Impact Factor, Indexing, Ranking

Alzheimers and Dementia Translational Research and Clinical Interventions Impact Factor, Indexing, Ranking

Alzheimers and Dementia Translational Research and Clinical Interventions (ADTRCI) is a scholarly journal dedicated to publishing research in the field of Medicine, and Published by John Wiley and Sons. and its abbreviation is Alzheimers Dement.


Alzheimers and Dementia Translational Research and Clinical Interventions Aim and Scope

Alzheimer’s & Dementia: Translational Research & Clinical Interventions (TRCI) is an open access journal seeking to bridge the full scope of explorations between basic research on drug discovery and clinical studies for all forms of dementia and Alzheimer's Disease. TRCI accelerates the conversion of abstract facts into practical knowledge of dementia and Alzheimer's Disease: specifically, to translate what is learned at the bench into bedside applications. TRCI is also interested in Clinical Trials. For more information, read the Editor-in-Chief’s strategic vision and expanded guidelines for manuscript submissions here. Review our Author Guidelines and submit your manuscript to TRCI.


Alzheimers and Dementia Translational Research and Clinical Interventions Details


Journal title Alzheimers and Dementia Translational Research and Clinical Interventions (ADTRCI)
Abbreviation Alzheimers Dement
Online ISSN 2352-8737
Publisher Name John Wiley and Sons
Editor-in-chief Barry D. Greenberg
Subject Category Medicine
Access type Open Access
Acceptance rate 64%
Impact Factor 4.8
SJR 1.800
SNIP 1.558
Ranking 1565
CiteScore 8.9
H-Index 49
Status 🟢 Active
Impact Factor List 2024

Who we are? Clarification: Journals Insights - Your Open Access Ally